Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases

Stopped early · Not applicable

Conditions studied: Inflammatory Arthritis, Scleroderma, Myositis, Sjogren's Syndrome, Systemic Lupus Erythematosus, Vasculitis

In brief

This study will assess the effect of a mindfulness meditation program administered via a smartphone application on health-related quality of life for patients with rheumatic disease.

Key facts

Study ID

NCT03937856

Run by

Johns Hopkins University

People needed

49

Starts

2019-05-07

Expected to finish

2021-04-22

Last updated by the study team

2021-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Established patients of the Johns Hopkins (JH) Rheumatology Division will be eligible for participation.
• Participants must have one of the following JH rheumatologist-diagnosed and/or confirmed diseases: inflammatory arthritis, scleroderma, myositis, Sjogren's syndrome, systemic lupus erythematosus, and vasculitis.
• Participants must be at least 18 years of age to participate; there is no upper-bound age limit
• Participants must have access to a smartphone or computer to access the Calm app (or webpage) as well as Redcap (which requires an email address) to access the questionnaires

You may not qualify if…

• None

Where it is running

• Johns Hopkins Bayview — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.